In Silico Design of a Trans‐Amplifying RNA‐Based Vaccine against SARS‐CoV‐2 Structural Proteins
F Nafian, G Soleymani, Z Pourmanouchehri… - Advances in …, 2024 - Wiley Online Library
Nucleic acid‐based vaccines allow scalable, rapid, and cell‐free vaccine production in
response to an emerging disease such as the current COVID‐19 pandemic. Here, we …
response to an emerging disease such as the current COVID‐19 pandemic. Here, we …